9 reports

These drugs are useful for treatment of inflammatory diseases, allergy, pain, , asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis, eczema, pruritus, itchy skin, urticaria etc.

  • Antifungal
  • Ear Disease
  • Pharmaceutical
  • Protein Therapy
  • Therapy

The data were presented at the European Academy of Allergy and Clinical Immunology ##th Annual Congress 2016.

  • Antifungal
  • Ear Disease
  • Pharmaceutical
  • Protein Therapy
  • Therapy

THE DRUG CANDIDATE ACTS BY TARGETING DIPEPTIDASE-##.

  • Antifungal
  • Digestive System Disorder
  • Ear Disease
  • Protein Therapy
  • Research And Development

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Digestive System Disorder
  • Pharmaceutical
  • Protein Therapy
  • Therapy

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Digestive System Disorder
  • Pharmaceutical
  • Protein Therapy
  • Therapy

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Digestive System Disorder
  • Protein Therapy
  • United States
  • Product Initiative

The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Antifungal
  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Protein Therapy
  • Therapy

The drug candidate acts by blocking the histamine receptors and prevents the excess mucus production associated with ocular allergy.

  • Antifungal
  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Protein Therapy
  • Therapy

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Digestive System Disorder
  • Infectious Disease
  • Protein Therapy
  • Therapy